CHPA and PCPC Comments Regarding Content and Format of Labeling for Human Nonprescription Drug Products Share page: Docket Number: FDA-2022-D-1837 Download Document Issues: OTC Medicines Other Issues Labeling Related Posts Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025 Press Releases and Statements Veteran Scientist & Regulator Joins CHPA’s Senior Management Team May 12, 2025 Press Releases and Statements CHPA Submits Official Comments on Section 232 National Security Investigation of Pharmaceuticals May 8, 2025